• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.45% Nasdaq Down1.03%

    Endo International plc (ENDP)

    -NasdaqGS
    79.61 Down 2.03(2.49%) Jan 30, 4:00PM EST
    |After Hours : 79.61 0.00 (0.00%) Jan 30, 5:47PM EST
    Add to Portfolio
    ProfileGet Profile for:
    Endo International plc
    Glandore Business Centres
    No. 33 Fitzwilliam Square
    Dublin, 2
    Ireland - Map
    Phone: 353 1 699 4700
    Website: http://www.endo.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Other
    Full Time Employees:3,371

    Business Summary 

    Endo International plc, a specialty healthcare company, develops, manufactures, markets, and distributes branded pharmaceutical and generic products, and medical devices worldwide. It provides branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar, and Fortesta Gel to treat and manage pain and conditions in urology, endocrinology, and oncology. The company also offers non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women’s health, and hypertension markets; and pharmaceutical products in the areas of ADHD, pain, urology, and allergy. In addition, it provides various medical devices comprising AMS 700 MS series, AMS 800 artificial urinary sphincters, GreenLight XPS laser systems, Elevate anterior and posterior pelvic floor repair systems, and Monarc subfascial hammock products in the areas of men’s and women’s health, and prostate health. The company’s products also include Aveed, an injectable testosterone preparation to treat male hypogonadism; and BEMA Buprenorphine, a transmucosal form of buprenorphine in Phase III trials for treating moderate to severe chronic pain. It serves pharmacy chains directly; and hospitals, governmental agencies, pharmacies, and physicians through wholesale drug distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Endo International plc

    Corporate Governance 
    Endo International plc’s ISS Governance QuickScore as of Jan 1, 2015 is 1. The pillar scores are Audit: 2; Board: 1; Shareholder Rights: 2; Compensation: 1.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
     PayExercised
    Mr. Rajiv Kanishka Liyanaarchchie De Silva , 48
    Chief Exec. Officer, Pres and Director
    6.56M0.00
    Mr. Suketu P. Upadhyay , 46
    Chief Financial Officer and Exec. VP
    569.00K0.00
    Ms. Caroline B. Manogue Esq., 46
    Chief Legal Officer, Exec. VP and Sec.
    1.20M2.09M
    Mr. Donald W. DeGolyer , 53
    Chief Operating Officer of Pharmaceuticals
    1.14M0.00
    Mr. Daniel A. Rudio ,
    Chief Accounting Officer, VP and Controller
    N/AN/A
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders